"Cabergoline, Levosimendan and Iabp: Treatment of Peripartum Cardiomyopathy"

نویسندگان

  • Silvia Donfrancesco
  • Marzia Cottini
  • Angela Lappa
  • Cecilia Nencini
  • Patrizia Picozzi
  • Fabio Sbaraglia
  • Vincenzo Polizzi
  • Paola Lilla Della Monica
  • Agnese Ricotta
  • Antonio Menichetti
  • Francesco Musumeci
چکیده

PeriPartum CardioMyopathy (PPCM) is a rare but potentially devastating cause of heart failure. We reported the case of a 31-year-old female who developed cardiogenic shock twelve hours post-delivery secondary to PPCM that was successfully treated with combined supportive care, including the cabergoline, levosimendan and IABP.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cabergoline in the Treatment of Peripartum Cardiomyopathy Cabergolina no tratamento da cardiomiopatia periparto

It is premature to make a recommendation for treatment of peripartum cardiomyopathy (PPCM) with prolactin inhibition (bromocriptine or cabergoline) as in the one-case report of Melo et al.1 There are now multiple reports of trials for PPCM subjects in the use prolactin inhibition treatment compared with non-use of this modality that show no statistically significant benefit in recovery outcomes...

متن کامل

Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan

Idiopathic peripartum cardiomyopathy presenting with heart failure is a true diagnostic and treatment challenge. Goal oriented clinical management aims at the relapse of left ventricular systolic dysfunction. A 35-year-old patient on her 12th day post-delivery presents progressive signs of heart failure. Transthoracic echocardiography showed severe mitral insufficiency, mild left ventricular dy...

متن کامل

Response: “Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: An Update”

We are very glad that our work got the attention of Dr. Biteker, and we wish to thank him for mentioning PPCM definition by ESC. According to workshop recommendations of National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) “peripartum cardiomyopathy is defined on the basis of 4 criteria, adopted from work by Demakis et al. (1, 2) which include th...

متن کامل

گزارش یک مورد Peripartum Cardiomyopathy کاردیومیوپاتی برق‌آسا متعاقب زایمان و بهبودی کامل در پیگیری دو ساله

Peripartum Cardiomyopathy (PPCM) is a rare and specific form of dilated and fatal cardiomyopathy which leads to systolic complication of the left ventricle. The disease usually begins slowly but its progression is fatal. Thus, the prognosis of the disease is often poor. Because of the low prevalence of the disease, extensive epidemiologic and clinical studies are not available. Few papers, most...

متن کامل

Peripartum cardiomyopathy.

Peripartum cardiomyopathy (PPCM) is a rare type of cardiomyopathy of unknown aetiology associated with significant mortality and morbidity and characterized by heart failure in late pregnancy or puerperium. Recently PPCM workshop committee has recommended inclusion of echocardiographic features of LV dysfunction to redefine PPCM. Subsequent pregnancies are associated with a very high mortality ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2016